These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2511802)

  • 1. Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.
    Bowie WR; Willetts V; Jewesson PJ
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1778-82. PubMed ID: 2511802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections.
    Bowie WR; Willetts V; Megran DW
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1774-7. PubMed ID: 2511801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833) for treatment of complicated urinary tract infections.
    Wolfhagen MJ; Hoepelman AI; Verhoef J
    Antimicrob Agents Chemother; 1990 Mar; 34(3):409-12. PubMed ID: 2110437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and tolerance of fleroxacin in patients with urethritis caused by Chlamydia trachomatis.
    Pust RA; Ackenheil-Köppe HR; Weidner W; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():227-30. PubMed ID: 3144543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complicated urinary infection in spinal injury patients: fleroxacin compared with ciprofloxacin.
    Whitby M; Angus L; Nimmo G; Hill V
    Chemotherapy; 1996; 42(6):468-72. PubMed ID: 8957583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single and multiple dose pharmacokinetics of fleroxacin.
    Weidekamm E; Portmann R; Partos C; Dell D
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():145-54. PubMed ID: 3144533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of fleroxacin coadministered with theophylline to young and elderly volunteers.
    Parent M; St-Laurent M; LeBel M
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1249-53. PubMed ID: 2118328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections.
    Iravani A
    Am J Med; 1993 Mar; 94(3A):89S-96S. PubMed ID: 8452189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
    Henry DC; Nenad RC; Iravani A; Tice AD; Mansfield DL; Magner DJ; Dorr MB; Talbot GH
    Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection.
    Kosmidis J; Gargalianos P; Adamis G; Petropoulou D; Makris D
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():219-21. PubMed ID: 3144541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photosensitivity induced by fleroxacin.
    Kimura M; Kawada A; Kobayashi T; Hiruma M; Ishibashi A
    Clin Exp Dermatol; 1996 Jan; 21(1):46-7. PubMed ID: 8689769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.
    Balfour JA; Todd PA; Peters DH
    Drugs; 1995 May; 49(5):794-850. PubMed ID: 7601015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of fleroxacin in gynecological infections].
    Matsuda S; Shimizu T; Cho N; Satoh K; Minaguchi H; Yagami Y; Okada H; Hirabayashi K; Deguchi K
    Jpn J Antibiot; 1991 Jun; 44(6):625-34. PubMed ID: 1909763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia.
    Marklein G
    Chemotherapy; 1996 Mar; 42 Suppl 1():33-42. PubMed ID: 8861533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya.
    MacDonald KS; Cameron DW; D'Costa L; Ndinya-Achola JO; Plummer FA; Ronald AR
    Antimicrob Agents Chemother; 1989 May; 33(5):612-4. PubMed ID: 2502065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photosensitivity induced by lomefloxacin with cross-photosensitivity to ciprofloxacin and fleroxacin.
    Kimura M; Kawada A
    Contact Dermatitis; 1998 Mar; 38(3):180. PubMed ID: 9536423
    [No Abstract]   [Full Text] [Related]  

  • 17. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
    Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y
    J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological response of mycoplasma to fleroxacin.
    Werk R; Schneider L
    Infection; 1989; 17(6):405-6. PubMed ID: 2515157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
    Naber KG; Allin DM; Clarysse L; Haworth DA; James IG; Raini C; Schneider H; Wall A; Weitz P; Hopkins G; Ankel-Fuchs D
    Int J Antimicrob Agents; 2004 Jun; 23(6):596-605. PubMed ID: 15194131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.